Market Overview:
Biopsy needle can be defined as a medical instrument used to perform a biopsy, which is a procedure to obtain a sample of cells from your body for laboratory testing. Common needle biopsy procedures include fine-needle aspiration and core needle biopsy. Needle biopsy may be used to take tissue or fluid samples from muscles, bones, and other organs, such as the liver or lungs. Globally, increasing prevalence of cancer and increasing healthcare spending are expected to drive the demand for biopsy needles during the period of study
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Forecast Period | 2022-2027 |
Historical Period | 2017-2021 |
Unit | Value (USD Million) |
Key Companies Profiled | CONMED Corporation (United States), Medtronic Plc (Ireland), Olympus (Japan), Becton, Dickinson and Company (United States), Boston Scientific Corporation (United States), Cook Group Incorporated (United States), Argon Medical Devices, Inc (United States), INRAD Inc. (United States), Somatex Medical Technologies (Germany) and Stryker Corporation (United States) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region or narrow down segments in the final scope subject to feasibility |
AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics of major and emerging geographies across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.
Key Players of Biopsy Needle Market Study:
CONMED Corporation (United States), Medtronic Plc (Ireland), Olympus (Japan), Becton, Dickinson and Company (United States), Boston Scientific Corporation (United States), Cook Group Incorporated (United States), Argon Medical Devices, Inc (United States), INRAD Inc. (United States), Somatex Medical Technologies (Germany) and Stryker Corporation (United States)
Biopsy Needle Market Segment Analysis
Scope | Sub-Segments |
---|
Application / End User | Tumor, Infection, Inflammation and Others |
Working | Fully Automatic,Semi-Automatic |
Utility | Disposable Needle,Non Disposable Needle |
End User | Hospitals,Clinics,Ambulatory Surgical Centers |
Influencing Trend:
Emergence of Liquid Biopsy
Market Growth Drivers:
Rising Prevalence of Cancer, Cancer Awareness Initiatives Undertaken By Governments and Global Health Organizations and Increasing Preference for Minimally Invasive Biopsies
Challenges:
Underdeveloped Healthcare Infrastructure and Dearth of Well-Trained Radiologists and Oncologists
Restraints:
Risk of Infections Associated With the use of Biopsy Needles
Opportunities:
Emerging Economies
Some of the other players that are also part of study are Cardinal Health (United States), Remington Medical (United States), HAKKO CO.,LTD (Japan) and Merit Medical Systems (United States). The Global Biopsy Needle market is gaining huge competition due to involvement of United States companies that constantly invest in research & development to meet market expectation with new innovation.
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Biopsy Needle market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Biopsy Needle market.
Identification of total players or companies operating in the global market which is further concentrated to fewer or most impacting players which are considered under the reports scope. In order to make a priority list sorting is done based on revenue generated based on the latest reporting with the help of paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Global Biopsy Needle Manufacturers and Suppliers, Research and Development Companies, Market Research and Consulting Service Providers and Academic Institutes and Universities.
This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.